Hepatitis B surface antigen (HBsAg) prevalence in Turkmenistan
Turkmenistan: Hepatitis B surface antigen (HBsAg) prevalence was 0.3% in 2024. ▼ Falling
Latest (2024)
0.3%
Change on year
unchanged
World rank
71st
of 194 countries
All-time high
0.5%
in 2015
All-time low
0.3%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Turkmenistan, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Turkmenistan recorded 0.3% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 40.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Turkmenistan peaked at 0.5% in 2015 and was at its lowest, 0.3%, in 2020.
Turkmenistan ranks 71st of 194 countries on this measure, in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Turkmenistan, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 0.5% | — |
| 2016 | 0.5% | +0.0% |
| 2017 | 0.4% | -20.0% |
| 2018 | 0.4% | +0.0% |
| 2019 | 0.4% | +0.0% |
| 2020 | 0.3% | -25.0% |
| 2021 | 0.3% | +0.0% |
| 2022 | 0.3% | +0.0% |
| 2023 | 0.3% | +0.0% |
| 2024 | 0.3% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.4% | 0.4% | 0.5% | 5 |
| 2020s | 0.3% | 0.3% | 0.3% | 5 |
Countries ranked near Turkmenistan
More health data for Turkmenistan
- Un projection of annual infant deaths, annual growth rate -1.61 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4813 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,169 deaths per 1,000 people (2090)
- Number of infants who die before age 1 549 deaths (2100)
- Population ages 0-14, female, annual growth rate 0.6771 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1526 units per person (2025)
- Population ages 0-14, male, annual growth rate 0.7784 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1596 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Turkmenistan?
- Hepatitis b surface antigen (hbsag) prevalence in Turkmenistan was 0.3% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Turkmenistan?
- The highest recorded value was 0.5% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Turkmenistan?
- The lowest recorded value was 0.3% in 2020.
- How does Turkmenistan rank for hepatitis b surface antigen (hbsag) prevalence?
- Turkmenistan ranks 71st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Turkmenistan?
- Over the last ten years it is down 40.0%. The long-run trend across the full record is falling.
- Where does this Turkmenistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).